Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.3 TWD
251.01 M TWD
1.11 B TWD
31.84 M
About SYN-TECH CHEM. & PHARM. CO
Sector
CEO
Yi Feng Wang
Headquarters
Tainan
Website
Founded
1982
ISIN
TW0001777001
FIGI
BBG000M116L4
SYN-TECH Chemical & Pharmaceutical Co., Ltd. engages in the research, development, and manufacture of active pharmaceutical ingredients. Its products include local anesthetics, cardiovascular drugs, muscle relaxants, respiratory drugs, central nervous system drugs, digestive system drugs, urinary system drugs, and topical drugs. The company was founded on November 9, 1982 and is headquartered in Tainan, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1777 is 93.6 TWD — it has increased by 0.54% in the past 24 hours. Watch SYN-TECH CHEM. & PHARM. CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SYN-TECH CHEM. & PHARM. CO stocks are traded under the ticker 1777.
1777 stock hasn't changed in a week, the month change is a −3.61% fall, over the last year SYN-TECH CHEM. & PHARM. CO has showed a 8.96% increase.
1777 reached its all-time high on Apr 14, 2021 with the price of 117.9 TWD, and its all-time low was 17.0 TWD and was reached on Oct 18, 2005. View more price dynamics on 1777 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1777 stock is 0.65% volatile and has beta coefficient of 0.28. Track SYN-TECH CHEM. & PHARM. CO stock price on the chart and check out the list of the most volatile stocks — is SYN-TECH CHEM. & PHARM. CO there?
Today SYN-TECH CHEM. & PHARM. CO has the market capitalization of 4.15 B, it has decreased by −0.21% over the last week.
Yes, you can track SYN-TECH CHEM. & PHARM. CO financials in yearly and quarterly reports right on TradingView.
SYN-TECH CHEM. & PHARM. CO is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
1777 net income for the last quarter is 116.02 M TWD, while the quarter before that showed 98.60 M TWD of net income which accounts for 17.66% change. Track more SYN-TECH CHEM. & PHARM. CO financial stats to get the full picture.
Yes, 1777 dividends are paid annually. The last dividend per share was 3.50 TWD. As of today, Dividend Yield (TTM)% is 3.76%. Tracking SYN-TECH CHEM. & PHARM. CO dividends might help you take more informed decisions.
SYN-TECH CHEM. & PHARM. CO dividend yield was 4.11% in 2023, and payout ratio reached 62.18%. The year before the numbers were 3.56% and 45.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 222.00 employees. See our rating of the largest employees — is SYN-TECH CHEM. & PHARM. CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYN-TECH CHEM. & PHARM. CO EBITDA is 459.95 M TWD, and current EBITDA margin is 35.31%. See more stats in SYN-TECH CHEM. & PHARM. CO financial statements.
Like other stocks, 1777 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYN-TECH CHEM. & PHARM. CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYN-TECH CHEM. & PHARM. CO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYN-TECH CHEM. & PHARM. CO stock shows the buy signal. See more of SYN-TECH CHEM. & PHARM. CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.